Compass Pathways Plc Equity-NMS: CMPS

Healthcare

Medical Care Facilities

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$10.3

52W high :

$32.55

1Y :

-64.02%

5Y :

-59.88%

Shares O/S :

42.58 M

Market cap :

435.13 M

What is the share price of Compass Pathways Plc today?

Compass Pathways Plc (CMPS) share price as of October 12, 2022, is $10.81. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Compass Pathways Plc?

Yes, Indian Investors can invest in the Compass Pathways Plc (CMPS) Share by opening an international trading account with Angel One.

How can I purchase Compass Pathways Plc shares in India?

Purchasing Compass Pathways Plc (CMPS) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Compass Pathways Plc (CMPS) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Compass Pathways Plc?

Yes, you can purchase fractional shares of Compass Pathways Plc (CMPS) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Compass Pathways Plc?

The market capitalization of Compass Pathways Plc on December 2, 2022, is $459.67 M.

In which sector Compass Pathways Plc belongs?

Compass Pathways Plc operates in the Healthcare sector, specifically in the Medical Care Facilities industry.

What documents are required to invest in Compass Pathways Plc stocks?

In order to invest in Compass Pathways Plc (CMPS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

COMPASS Pathways plc is a United Kingdom-based mental healthcare company. The Company is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression (TRD). The Company has developed COMP360, which is a psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin. The Company's COMP360 has completed a Phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America. Its randomized controlled Phase IIb study of psilocybin therapy in treatment-resistant depression is the psilocybin therapy clinical trial, with approximately 233 patients across 22 sites in 10 European and North American countries. This trial assessed the safety and efficacy of COMP360 psilocybin therapy in three doses: 1mg, 10mg, 25mg. The Company is also running a Phase II clinical trial of COMP360 psilocybin therapy for post-traumatic stress disorder (PTSD).